A Phase I/II Trial of Pertuzumab in Combination With Cetuximab and Irinotecan in Previously Treated Metastatic Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2015
At a glance
- Drugs Pertuzumab (Primary) ; Cetuximab; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Mar 2015 Status changed from discontinued to completed as reported by ClinicalTrials.gov
- 22 Feb 2015 Status changed from active, no longer recruiting to discontinued according to ClinicalTrials.gov.
- 14 Jan 2013 Planned end date changed from 1 Oct 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.